Literature DB >> 11911820

A T cell receptor CDR3beta loop undergoes conformational changes of unprecedented magnitude upon binding to a peptide/MHC class I complex.

Jean Baptiste Reiser1, Claude Grégoire, Claudine Darnault, Thomas Mosser, Annick Guimezanes, Anne Marie Schmitt-Verhulst, Juan Carlos Fontecilla-Camps, Gilbert Mazza, Bernard Malissen, Dominique Housset.   

Abstract

The elongated complementary-determining region (CDR) 3beta found in the unliganded KB5-C20 TCR protrudes from the antigen binding site and prevents its docking onto the peptide/MHC (pMHC) surface according to a canonical diagonal orientation. We now present the crystal structure of a complex involving the KB5-C20 TCR and an octapeptide bound to the allogeneic H-2K(b) MHC class I molecule. This structure reveals how a tremendously large CDR3beta conformational change allows the KB5-C20 TCR to adapt to the rather constrained pMHC surface and achieve a diagonal docking mode. This extreme case of induced fit also shows that TCR plasticity is primarily restricted to CDR3 loops and does not propagate away from the antigen binding site.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11911820     DOI: 10.1016/s1074-7613(02)00288-1

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  79 in total

1.  A single residue exchange between two HLA-B27 alleles triggers increased peptide flexibility.

Authors:  Ewgeni B Starikov; Ewgeni B Starikow; Lennart Nilsson; Martin Hülsmeyer
Journal:  Eur Biophys J       Date:  2004-03-10       Impact factor: 1.733

2.  Evolving concepts of specificity in immune reactions.

Authors:  Herman N Eisen; Arup K Chakraborty
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

Review 3.  Unusual features of self-peptide/MHC binding by autoimmune T cell receptors.

Authors:  Melissa J Nicholson; Michael Hahn; Kai W Wucherpfennig
Journal:  Immunity       Date:  2005-10       Impact factor: 31.745

4.  Structural basis of affinity maturation and intramolecular cooperativity in a protein-protein interaction.

Authors:  Sangwoo Cho; Chittoor P Swaminathan; Jianying Yang; Melissa C Kerzic; Rongjin Guan; Michele C Kieke; David M Kranz; Roy A Mariuzza; Eric J Sundberg
Journal:  Structure       Date:  2005-12       Impact factor: 5.006

5.  Epitope-specificity of recombinant antibodies reveals promiscuous peptide-binding properties.

Authors:  Niclas Olsson; Stefan Wallin; Peter James; Carl A K Borrebaeck; Christer Wingren
Journal:  Protein Sci       Date:  2012-10-25       Impact factor: 6.725

6.  Conformational changes within the HLA-A1:MAGE-A1 complex induced by binding of a recombinant antibody fragment with TCR-like specificity.

Authors:  Pravin Kumar; Ardeschir Vahedi-Faridi; Wolfram Saenger; Andreas Ziegler; Barbara Uchanska-Ziegler
Journal:  Protein Sci       Date:  2009-01       Impact factor: 6.725

7.  Structures of MART-126/27-35 Peptide/HLA-A2 complexes reveal a remarkable disconnect between antigen structural homology and T cell recognition.

Authors:  Oleg Y Borbulevych; Francis K Insaidoo; Tiffany K Baxter; Daniel J Powell; Laura A Johnson; Nicholas P Restifo; Brian M Baker
Journal:  J Mol Biol       Date:  2007-07-26       Impact factor: 5.469

8.  TCR scanning of peptide/MHC through complementary matching of receptor and ligand molecular flexibility.

Authors:  William F Hawse; Soumya De; Alex I Greenwood; Linda K Nicholson; Jaroslav Zajicek; Evgenii L Kovrigin; David M Kranz; K Christopher Garcia; Brian M Baker
Journal:  J Immunol       Date:  2014-02-12       Impact factor: 5.422

Review 9.  To affinity and beyond: harnessing the T cell receptor for cancer immunotherapy.

Authors:  Jessica E Thaxton; Zihai Li
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

10.  Vaccine adjuvants alter TCR-based selection thresholds.

Authors:  Laurent Malherbe; Linda Mark; Nicolas Fazilleau; Louise J McHeyzer-Williams; Michael G McHeyzer-Williams
Journal:  Immunity       Date:  2008-05-01       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.